According to Onconova Therapeutics's latest financial reports the company's current EPS (TTM) is -0,80ย โฌ. In 2014 the company made an earnings per share (EPS) of -5.601ย โฌ an increase over its 2013 EPS that were of -7.037ย โฌ.